US FDA On Effects From Cannabinoids Potentially Differing By Gender: Stay Tuned
For Pregnant Women, Research Points To CBD Label Warnings
Executive Summary
"The use of these products during pregnancy and lactation raises additional questions and concerns,” says Kaveeta Vasisht, FDA Office of Women’s Health director. "There is a great deal that we simply do not yet know about CBD and beyond CBD, even more that we do not know about the other compounds found in hemp," said Douglas Throckmorton, Center for Drug Evaluation and Research deputy director.